These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 15574393)
1. The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis. Zhou HE; Nothnick WB Front Biosci; 2005 Jan; 10():569-75. PubMed ID: 15574393 [TBL] [Abstract][Full Text] [Related]
2. Paracrine regulation of matrix metalloproteinase expression in endometriosis. Sharpe-Timms KL; Cox KE Ann N Y Acad Sci; 2002 Mar; 955():147-56; discussion 157-8, 396-406. PubMed ID: 11949944 [TBL] [Abstract][Full Text] [Related]
3. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Sillem M; Prifti S; Koch A; Neher M; Jauckus J; Runnebaum B Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):167-74. PubMed ID: 11301163 [TBL] [Abstract][Full Text] [Related]
4. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2. Uzan C; Cortez A; Dufournet C; Fauvet R; Siffroi JP; Daraï E Virchows Arch; 2004 Dec; 445(6):603-9. PubMed ID: 15452706 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis. Szymanowski K; Mikołajczyk M; Wirstlein P; Dera-Szymanowska A Ann Agric Environ Med; 2016 Dec; 23(4):649-653. PubMed ID: 28030938 [TBL] [Abstract][Full Text] [Related]
6. Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis. Barbe AM; Berbets AM; Davydenko IS; Koval HD; Yuzko VO; Yuzko OM J Med Life; 2020; 13(3):314-320. PubMed ID: 33072202 [TBL] [Abstract][Full Text] [Related]
7. Expression of Matrix Metalloproteinases and Their Inhibitors in Endometrium: High Levels in Endometriotic Lesions. Luddi A; Marrocco C; Governini L; Semplici B; Pavone V; Luisi S; Petraglia F; Piomboni P Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325785 [TBL] [Abstract][Full Text] [Related]
8. The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review). Bałkowiec M; Maksym RB; Włodarski PK Mol Med Rep; 2018 Sep; 18(3):3123-3136. PubMed ID: 30066912 [TBL] [Abstract][Full Text] [Related]
9. [Matrix metalloproteinases and their role in menstruation and endometriosis]. Hudelist G; Singer CF; Keckstein J Zentralbl Gynakol; 2005 Oct; 127(5):320-4. PubMed ID: 16195977 [TBL] [Abstract][Full Text] [Related]
10. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Osteen KG; Keller NR; Feltus FA; Melner MH Gynecol Obstet Invest; 1999; 48 Suppl 1():2-13. PubMed ID: 10559659 [TBL] [Abstract][Full Text] [Related]
11. Matrix metallopeptidase expression and modulation by transforming growth factor-β1 in equine endometrosis. Szóstek-Mioduchowska A; Słowińska M; Pacewicz J; Skarzynski DJ; Okuda K Sci Rep; 2020 Jan; 10(1):1119. PubMed ID: 31980722 [TBL] [Abstract][Full Text] [Related]
12. Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis. Osteen KG; Bruner-Tran KL; Ong D; Eisenberg E Ann N Y Acad Sci; 2002 Mar; 955():139-46; discussion 157-8, 396-406. PubMed ID: 11949943 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and TACE play a role in the pathogenesis of endometriosis. Gottschalk C; Malberg K; Arndt M; Schmitt J; Roessner A; Schultze D; Kleinstein J; Ansorge S Adv Exp Med Biol; 2000; 477():483-6. PubMed ID: 10849774 [TBL] [Abstract][Full Text] [Related]
14. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis. Ueda M; Yamashita Y; Takehara M; Terai Y; Kumagai K; Ueki K; Kanda K; Hung YC; Ueki M Gynecol Endocrinol; 2002 Oct; 16(5):391-402. PubMed ID: 12587534 [TBL] [Abstract][Full Text] [Related]
15. Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis. Osteen KG; Bruner-Tran KL; Keller NR; Eisenberg E Ann N Y Acad Sci; 2002 Mar; 955():37-47; discussion 86-8, 396-406. PubMed ID: 11949963 [TBL] [Abstract][Full Text] [Related]
16. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Braundmeier AG; Nowak RA Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716 [TBL] [Abstract][Full Text] [Related]
17. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. Bruner-Tran KL; Eisenberg E; Yeaman GR; Anderson TA; McBean J; Osteen KG J Clin Endocrinol Metab; 2002 Oct; 87(10):4782-91. PubMed ID: 12364474 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Chung HW; Lee JY; Moon HS; Hur SE; Park MH; Wen Y; Polan ML Fertil Steril; 2002 Oct; 78(4):787-95. PubMed ID: 12372458 [TBL] [Abstract][Full Text] [Related]
19. Curcumin delays endometriosis development by inhibiting MMP-2 activity. Jana S; Rudra DS; Paul S; Snehasikta S Indian J Biochem Biophys; 2012 Oct; 49(5):342-8. PubMed ID: 23259320 [TBL] [Abstract][Full Text] [Related]
20. Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Cox KE; Piva M; Sharpe-Timms KL Biol Reprod; 2001 Oct; 65(4):1297-303. PubMed ID: 11566756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]